Carregant...
Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1
The soluble vascular endothelial growth factor (VEGF) receptor 1 (sFLT1) has been tested in both animals and humans for anti-angiogenic therapies, e.g., age-related macular degeneration. We hypothesized that adeno-associated viral vector (AAV)-mediated sFLT1 expression could be used to inhibit abnor...
Guardat en:
| Publicat a: | Gene Ther |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636448/ https://ncbi.nlm.nih.gov/pubmed/26090874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2015.57 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|